WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, maker Gilead Sciences announced ...

It is unbelievable, the insight you get from the jurors after they have sat on [a jury],” Geragos told News Nation about his own experiences working with previous jurors like George.

HASTINGS, Neb. (KSNB) - Good Wednesday evening everyone! The weather will be quiet this evening and overnight. If you have a chance, you may want to get outside and enjoy the weather this evening as ...

The Federal Reserve kept its key rate unchanged Wednesday as it waits for additional information on how tariffs and other ...

WE’VE GOTTEN ALL SEC SEMIFINAL SHOWDOWN HERE AT CHARLES SCHWAB FIELD, ARKANSAS, SECURING ITS SPOT WITH A73 WIN OVER UCLA LAST NIGHT. AND NOW THEY’LL BE MET BY NONE OTHER THAN LSU. NOW, FOR BETTER OR ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show prevents new infections.

Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking a major advance in battling AIDS. Yeztugo was approved by the FDA ...

The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have paid for it in low-income countries.

Penn Entertainment's reliance on ESPN's brand for ESPN Bet appears to be repeating past mistakes made with Barstool. Click ...

Alabama men’s basketball has its SEC opponents set for the 2025-26 season. The Crimson Tide will face Arkansas, Auburn, Kentucky, Mississippi State, Missouri, South Carolina, Tennessee, Texas and ...